- Home
- PTSI vs TRML Comparison
PTSI vs TRML Comparison
Compare PTSI & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTSI
- TRML
- Stock Information
- Founded
- PTSI 1980
- TRML 2021
- Country
- PTSI United States
- TRML United States
- Employees
- PTSI N/A
- TRML N/A
- Industry
- PTSI Trucking Freight/Courier Services
- TRML Biotechnology: Pharmaceutical Preparations
- Sector
- PTSI Industrials
- TRML Health Care
- Exchange
- PTSI Nasdaq
- TRML Nasdaq
- Market Cap
- PTSI N/A
- TRML 419.1M
- IPO Year
- PTSI 1985
- TRML N/A
- Fundamental
- Price
- PTSI $17.32
- TRML $29.13
- Analyst Decision
- PTSI Hold
- TRML Strong Buy
- Analyst Count
- PTSI 1
- TRML 5
- Target Price
- PTSI $17.00
- TRML $61.80
- AVG Volume (30 Days)
- PTSI 19.1K
- TRML 335.7K
- Earning Date
- PTSI 10-25-2024
- TRML 11-12-2024
- Dividend Yield
- PTSI N/A
- TRML N/A
- EPS Growth
- PTSI N/A
- TRML N/A
- EPS
- PTSI 0.06
- TRML N/A
- Revenue
- PTSI $747,211,000.00
- TRML N/A
- Revenue This Year
- PTSI N/A
- TRML N/A
- Revenue Next Year
- PTSI $11.17
- TRML N/A
- P/E Ratio
- PTSI $306.27
- TRML N/A
- Revenue Growth
- PTSI N/A
- TRML N/A
- 52 Week Low
- PTSI $13.51
- TRML $9.18
- 52 Week High
- PTSI $22.88
- TRML $48.31
- Technical
- Relative Strength Index (RSI)
- PTSI 48.50
- TRML 71.27
- Support Level
- PTSI $16.50
- TRML $23.90
- Resistance Level
- PTSI $18.11
- TRML $28.87
- Average True Range (ATR)
- PTSI 0.70
- TRML 1.61
- MACD
- PTSI 0.01
- TRML -0.14
- Stochastic Oscillator
- PTSI 42.80
- TRML 99.05
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.